Location History:
- Milan, IT (1991)
- Lodi, IT (1991)
Company Filing History:
Years Active: 1991
Title: Lavezzo Antonio: Innovator in Pharmacological Compounds
Introduction
Lavezzo Antonio is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmacology, particularly through his innovative compounds. With a total of three patents to his name, Antonio's work focuses on developing novel therapeutic agents.
Latest Patents
Antonio's latest patents include the development of pharmacologically active piperidinylimidazopyridine compounds. These compounds are characterized by their unique formula, where R represents an alkoxyalkyl radical containing 4 to 6 carbon atoms, an optionally substituted benzyl radical, or a tetrahydrofurfuryl radical. These compounds exhibit interesting antihistaminic and antiallergic activity, making them valuable in medical applications. Another significant patent involves pharmacologically active aminoimidazopyridines, which are novel imidazopyridine derivatives. In this case, R represents an alkoxyalkyl radical having 4-6 carbon atoms or a benzyl radical that may be optionally substituted by a halogen atom, an alkyl, or an alkoxy radical with up to 3 carbon atoms.
Career Highlights
Antonio is currently associated with Dompe' Farmaceutici S.p.a., a company known for its focus on pharmaceutical innovations. His work at Dompe' has allowed him to explore and develop new compounds that have the potential to address various medical conditions.
Collaborations
Antonio collaborates with esteemed colleagues such as Giani P Roberto and Parini Ettore. Their combined expertise contributes to the advancement of pharmacological research and the development of new therapeutic solutions.
Conclusion
Lavezzo Antonio stands out as an influential inventor in the field of pharmacology. His innovative patents and collaborations reflect his commitment to advancing medical science. His contributions are likely to have a lasting impact on the development of new treatments.